Title : Therapeutic Options for the Management of Postprandial Glucose in Patients With Type 2 Diabetes on Basal Insulin.

Pub. Date : 2015 Oct

PMID : 26487791






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In Brief For patients with type 2 diabetes who require add-on therapy to metformin plus basal insulin, GLP-1 receptor agonists may be a favorable option because they effectively manage postprandial glucose, reduce body weight, and have an overall favorable safety profile compared to other agents. Metformin glucagon like peptide 1 receptor Homo sapiens